This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Mario Maj, MD, PhD; Raffaele Pirozzi, MD; Dargut Kemali, MD
Department of Psychiatry First Medical School University of Naples Largo Madonna delle Grazie 80138 Napoli, Italy

Arch Gen Psychiatry. 1991;48(8):772.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.—

Harrow and colleagues¹ rightly pointed out that, in routine clinical practice, lithium carbonate treatment is an effective prophylaxis for fewer than the 70% to 80% of manic patients previously described.

The validity of their statement is even more evident if bipolar patients are followed up for more than the 1.7 years after hospital discharge Harrow et al used in their investigation, and it even holds in patients whose initial response to lithium carbonate had been favorable.

Extending the sample described in a previous report,² we studied 50 patients with a DSM-III diagnosis of bipolar affective disorder who had completed a 2-year prophylactic treatment program with lithium carbonate and had been classified as responders, having had no relapse despite a reasonably high risk of recurrence (ie, history of at least one affective episode during the 2-year period preceding the index episode and the start of lithium . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?